Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Eosinophil count

ZNF365 · rs10995246

Strength of the evidence

3 / 4

Its strongest genetic-study result is p = 10−74, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 408,112 British individuals.

The effect Each copy of the A allele shifted the measure 0.0502 lower (95% confidence interval 0.045-0.056); p = 7 × 10−75.

How common The A allele had a frequency of about 37% in the people studied.

Where it sits Chromosome 10, band 10q21.2 — in an intron of LINC02929.

How common each version is

AC
Korean KRGDB
A 44.6% · C 55.4%
Korean Korea4K
A 45.2% · C 54.8%
Korean Korea1K
A 47.3% · C 52.7%
Japanese ToMMo
A 33.0% · C 67.0%
Vietnamese
A 51.9% · C 48.1%
World gnomAD
A 29.0% · C 71.0%
World 1000 Genomes
A 29.7% · C 70.3%
World TOPMed
A 27.3% · C 72.7%

By ancestry gnomAD

East Asian
A 51.2% · C 48.8%
European (non-Finnish)
A 37.2% · C 62.8%
African / African American
A 12.4% · C 87.6%
South Asian
A 37.6% · C 62.4%
Admixed American (Latino)
A 21.7% · C 78.3%
Middle Eastern
A 30.5% · C 69.5%
Finnish
A 34.0% · C 66.0%
Ashkenazi Jewish
A 39.2% · C 60.8%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to Eosinophil count. That is the strongest link of the three results. A link in a study is not a diagnosis.
A/C One copy of the version the research linked to Eosinophil count. That is a smaller link than two copies.
C/C No copy of the version the research linked to Eosinophil count. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Eosinophil count (rs10995246). MyGeneLog™. https://www.mygenelog.com/variants/rs10995246

← See all variants